Search

everythinglearnresearchcommunity

for

Search:↓

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Beard and scalp hair cells have different gene expressions, which may affect beard growth characteristics.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

Prostaglandin E2 affects human platelet activity in complex ways that could lead to personalized heart disease treatments.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Combining laser hair removal with topical eflornithine is recommended for better results in treating unwanted facial hair.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Hair loss in teenagers is hard to treat and lacks a cure, with some treatments available depending on the type of hair loss.

Vegetarian Indian women with PCOS have higher inflammation levels than non-vegetarians.

Ginsenoside Rb1 from Panax ginseng helps mink hair grow by activating certain cell signals.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.